| Chesterfield Speech-language Services, Llc | |
|
9311 Southport Dr, North Chesterfield, VA 23235-4933 | |
| (804) 677-6966 | |
| Not Available |
| Full Name | Chesterfield Speech-language Services, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 9311 Southport Dr, North Chesterfield, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033590963 | NPI | - | NPPES |
| 2202002757 | Other | VA | VIRGINIA BOARD OF AUDIOLOGY AND SPEECH-LANGUAGE PATHOLOGY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202002757 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chesterfield Speech-language Services, Llc Po Box 36307, North Chesterfield, VA 23235-8006 Ph: (804) 677-6966 | Chesterfield Speech-language Services, Llc 9311 Southport Dr, North Chesterfield, VA 23235-4933 Ph: (804) 677-6966 |
News Archive
Researchers have long surmised that management techniques successful in manufacturing and technology sectors may improve health care quality. However, there has been very little evidence about how these practices are disseminated in hospitals and whether they are associated with better performance.
An experimental drug recently concluded a successful third-phase clinical trial and could potentially offer a new treatment for about 300,000 Canadians who have worsening chronic heart failure.
A relatively simple electronic gadget could speed up HIV/AIDS diagnostics and improve accuracy particularly in parts of the world with very limited access to healthcare workers. The device is described in the International Journal of Biomedical Engineering and Technology.
The CHIME Foundation, which represents more than 1,400 of the healthcare industry's leading Chief Information Officers, named Glen Tullman, Chief Executive Officer of Allscripts, the 2011 winner of its Lifetime Achievement Award.
La Jolla Pharmaceutical Company today announced that it has received "fast track" designation for Riquent (abetimus sodium) for the treatment of lupus renal disease from the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
Paige Sapp, M,S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 206 Twinridge Ln Ste A, North Chesterfield, VA 23235 Phone: 804-323-9060 | |
U-speak, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 411 Branchway Rd Ste 108, North Chesterfield, VA 23236 Phone: 804-399-5815 | |
Miss Rebecca Hayden Saur, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 Fax: 757-490-2936 | |
Miss Carrie Lynn Willis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 Fax: 757-490-2936 | |
Nikki Rose Karnes, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7401 Beaufont Springs Dr Ste 205, North Chesterfield, VA 23225 Phone: 804-272-0114 | |
Jennifer Znotens, M,A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7401 Beaufont Spring Dr, Suite 205, North Chesterfield, VA 23225 Phone: 804-272-0114 Fax: 804-272-1125 |